Phase II trial of dolastatin-10, a novel anti-tubulin agent, in metastatic soft tissue sarcomas

Margaret Von Mehren, S. P. Balcerzak, A. S. Kraft, J. H. Edmonson, S. H. Okuno, M. Davey, S. McLaughlin, M. T. Beard, A. Rogatko

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of dolastatin-10, a novel anti-tubulin agent, in metastatic soft tissue sarcomas'. Together they form a unique fingerprint.

Medicine & Life Sciences